Cargando…
Intra-Articular Drug Delivery for Osteoarthritis Treatment
Osteoarthritis (OA) is the most prevalent degenerative joint disease affecting millions of people worldwide. Currently, clinical nonsurgical treatments of OA are only limited to pain relief, anti-inflammation, and viscosupplementation. Developing disease-modifying OA drugs (DMOADs) is highly demande...
Autores principales: | Cao, Yifeng, Ma, Yifeng, Tao, Yi, Lin, Weifeng, Wang, Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8703898/ https://www.ncbi.nlm.nih.gov/pubmed/34959445 http://dx.doi.org/10.3390/pharmaceutics13122166 |
Ejemplares similares
-
Knee Osteoarthritis Therapy: Recent Advances in Intra-Articular Drug Delivery Systems
por: Ma, Luoyang, et al.
Publicado: (2022) -
Osteoarthritis In Vitro Models: Applications and Implications in Development of Intra-Articular Drug Delivery Systems
por: Salgado, Carlota, et al.
Publicado: (2021) -
Nanoparticle–Cartilage Interaction: Pathology-Based Intra-articular Drug Delivery for Osteoarthritis Therapy
por: Li, Xu, et al.
Publicado: (2021) -
Biomaterial-engineered intra-articular drug delivery systems for osteoarthritis therapy
por: Kou, Longfa, et al.
Publicado: (2019) -
Intra-articular use of hyaluronic acid in the treatment of osteoarthritis
por: Migliore, Alberto, et al.
Publicado: (2008)